An Evaluation of Quality of Life Outcomes in Cancer Patients Receiving Home Parenteral
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Quality of Life
研究概览
简要总结
This study is being done to examine the effect of Parenteral (intravenous) nutrition support in the home setting on quality of life in cancer patients. In addition, this study is being done to examine the effect of home parenteral nutrition on the use of pain and anti-nausea medication.
详细描述
This is a prospective descriptive non-randomized clinical study to examine quality of life outcomes and use of pain and anti-emetic therapy for patients receiving HPN support. The EORTC QLQ-C30 will be used to evaluate quality of life. All subjects will be monitored monthly throughout the course of treatment for a minimum of 3 months and a maximum of 1 year.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with a cancer diagnosis who have been receiving parenteral nutrition in the hospital or have started on HPN while at Cancer Treatment Centers of America and meet the criteria for home parenteral nutrition.
- •Patient expected to have a life expectancy of greater than 90 days post discharge.
排除标准
- •Patients less than 18 years of age
- •HPN patients who do not receive nutrition assessment and follow-up by the Coram Healthcare nutrition support team
- •Refuse to participate
结局指标
主要结局
Quality of Life
时间窗: Monthly for a minimum of 3 months to a maximum of 12 months
To examine the effect of parenteral nutrition support in the home care setting on quality of life as measured by the EORTC QLQ-C30
次要结局
- Pain and nausea medication usage(Monthly for a minumum of 3 months to a maximum of 12 months)